Daxor Co. (NYSEAMERICAN:DXR) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.00 and traded as high as $9.88. Daxor shares last traded at $9.88, with a volume of 400 shares traded.
A number of research analysts recently commented on DXR shares. Ascendiant Capital Markets started coverage on Daxor in a research report on Thursday, May 16th. They issued a “buy” rating and a $20.00 price target on the stock. Maxim Group started coverage on Daxor in a research report on Monday, July 29th. They issued a “buy” rating and a $22.00 price target on the stock.
Daxor Company Profile (NYSEAMERICAN:DXR)
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia.
Recommended Story: How to use beta for portfolio diversification
Receive News & Ratings for Daxor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daxor and related companies with MarketBeat.com's FREE daily email newsletter.